Primary non-Hodgkin’s lymphomas of the breast: 23 years of experience at the Colombian National Cancer Institute

Authors

  • Myriam Rodríguez Instituto Nacional de Cancerología
  • Marco Grajales Instituto Nacional de Cancerología
  • Sonia Londoño Instituto Nacional de Cancerología
  • Natascha Ortiz Instituto Nacional de Cancerología

Keywords:

Lymphoma, breast lymphoma, extranodal, non-Hodgkin’s lymphomas, breast cancer

Abstract

Introducción: Primary non-Hodgkin’s lymphomas of the breast (PNHLB) are an infrequent malignancy. In a review of the literature, in which six Latin American journals are included, approximately 450 cases have been reported during the past two decades. In this paper we present the experience of the National Cancer Institute of Colombia during the last 23 years.
Objective: To carry out a retrospective analysis of the characteristics, natural history, prognostic factors, and outcome of patients with PNHLB at the nci of Colombia.
Methods: The medical histories of patients diagnosed with PNHLB between 1980 and 2003 were reviewed; likewise, the clinical characteristics, treatment protocols, and final outcomes were analyzed.
Results: 25 patients were identified as PNHLB. The average follow-up was 57 months. The medium age was 58, ranging from 26 to 83. 84% had diffused large cell lymphoma. The Kamofsky index was over 80 in 92 % of the patients. 72% received CHOP chemotherapy. Two patients received a combination without doxorubicin. 68% received combined chemo- and radiation therapy. Two patients refused therapy. Two patients died before receiving any type of treatment. CNS compromise was observed in 20% of patients during the evolution of their disease. The youngest patient, whose case deserves special comment, obtained a second complete remission with simple mastectomy, after having relapsed after conventional chemotherapy, radiotherapy, and autologous bone marrow transplant. No significant prognostic variables were found using the univariate analysis.
Conclusions: A high rate of complete remission can be achieved by using combined treatment in patients with PNHLB. The medium overall survival was not reached after 71 months of follow-up. The most frequent relapse site was the cns.

Author Biographies

Myriam Rodríguez, Instituto Nacional de Cancerología

Instituto Nacional de Cancerología, E.S.E, Clínica de Hematología y Trasplante de Médula Ósea, Bogotá D.C.

Marco Grajales, Instituto Nacional de Cancerología

Instituto Nacional de Cancerología, E.S.E, Clínica de Hematología y Trasplante de Médula Ósea, Bogotá D.C.

Sonia Londoño, Instituto Nacional de Cancerología

Instituto Nacional de Cancerología, E.S.E, Especialista en Entrenamiento, Clínica de Ginecología Oncológica, Bogotá D.C.

Natascha Ortiz, Instituto Nacional de Cancerología

Instituto Nacional de Cancerología, E.S.E, Grupo Investigación Clínica, Bogotá D.C.

References

Tucker M, Lin A. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. En: Candios G, Lister T, Sklar J. eds. The Lymphomas. Philadelphia: W. B. Saunders; 1998.p.43-62.

Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behaviour. Semin Oncol 1999;26:357-364.

Hugh J, Jackson F, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990;66:2602-2611.

https://doi.org/10.1002/1097-0142(19901215)66:12<2602::AID-CNCR2820661224>3.0.CO;2-U

Cohen P, Brooks J. Lymphomas of the breast: a clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer 1991; 67:1359-1369.

https://doi.org/10.1002/1097-0142(19910301)67:5<1359::AID-CNCR2820670515>3.0.CO;2-4

Giardini R, Piccolo C, Rilke F. Primary non- Hodgkin's lymphomas of the female breast. Cancer 1992;69:725-735.

https://doi.org/10.1002/1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-C

Mattia AR, Ferry JA, Harris NL. Breast lymphoma. Am J Surg Pathol 1992;17:574-587.

https://doi.org/10.1097/00000478-199306000-00005

Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1992;29:1705-1712.

https://doi.org/10.1002/1097-0142(197206)29:6<1705::AID-CNCR2820290640>3.0.CO;2-I

Shipp M. The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.

https://doi.org/10.1056/NEJM199309303291402

Domchek S, Hecht J, Fleming M, Pinkus G, Canellos G. Lymphomas of the breast. Primary and secondary involvement. Cancer 2002;94:6-13.

https://doi.org/10.1002/cncr.10163

Jeon JH, Akagi T, Hoshida Y, Hayashi K et al. Primary non-Hodgkin's malignant lymphoma of the breast. An immunohistochemical study of seven patients and literature review of 152 patients with breast lymphoma in Japan. Cancer 1992;70:2451- 2459.

https://doi.org/10.1002/1097-0142(19921115)70:10<2451::AID-CNCR2820701011>3.0.CO;2-B

Harris NL, Jaffe E, Stein H et al. A revised Euro- pean-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361.

https://doi.org/10.1182/blood.V84.5.1361.1361

Burke J. Extranodal lymphoid proliferations: general principles and differential diagnosis. En: Knowles M. Neoplastic Hematopathology. 2ed. London: Lippincott and Wilkins; 2001.p.l374-1388.

Harris NL, Jaffe E, Lister A, Bloomfield C, Diebold J. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the.clinical advisory committee meeting (Airlie House, Virginia, November 1997) [special article]. J Clin Oncol 1999;17:3835-3849.

https://doi.org/10.1200/JCO.1999.17.12.3835

Pacheco C, Padrón Y, Herrera JA, Muñoz LC, Moreno L, Gómez P, Soler C, Barrios G. Linfoma primario de mama: presentación de 3 casos y revisión de la literatura. Rev Venez Oncol 2002; 14(l):35-39.

Díaz CM, Barroso MC, Vázquez E, Expósito G, Pérez A. Linfoma no Hodgkin primario de la mama. Presentación de 6 casos y revisión de la literatura. Rev Cubana Oncol 2001;17:210-216.

Medeiros CR, Pupo F, Moreira C G. Linfoma primario de mama: relato de la presentación clínica de 6 pacientes. Rev Méd Paraná 2000;58:5-7.

Bittencourt R, Leite MA, Job E Linfoma imunoblástico primário do corpo uterino-metástases em mama e sistema nervoso central: relato de caso e revisáo da literatura. Bol Soc Bras Hematol Hemoter 1998;20:27-36.

Trindade DM, Defferrari R, Sousa RM, Lazzaron AR, Fuñan RD, Borba AA. Linfoma primário de mama. Rev Bras Mastologia 1999;9:41-45.

Corzo D, Escallón J, Castro C, García C. Linfoma primario de seno. Presentación de un caso. Acta Méd Colomb 1992;17:443-447.

Flores G, Ugalde, MT, Herrera A, González E, Aaron JL, Meneses A, Alcalá F. Linfoma primario de la glándula mamaria: lesión linfoepitelial asociada a linfoma maligno: reporte de un caso y revisión de la literatura. Rev Inst Nac Cancero! 1993;39: 1881-1885.

Gholam D, Bibeau F, El-Weshi A, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma 2003;44:1173-1178.

https://doi.org/10.1080/1042819031000079195

Ribrag V, Bibeau F, Gholam D, Elweshi A. Primary breast lymphoma: a report of 20 cases. Br J Haematol 2001;115:253-255.

https://doi.org/10.1046/j.1365-2141.2001.03047.x

Topalovski M, Crisan D, Mattson J. Lymphoma of the breast. A clinicopathologic study of primary and secondary cases. Arch Pathol Lab Med 1999; 123: 1208-1218.

Armitage JO, Feagler JR, Skoog DP. Burkitt's lymphoma during pregnancy with bilateral breast involvement, jama 1977;237:151.

https://doi.org/10.1001/jama.1977.03270290051027

Wong W, SchildS, Halyard M, SchombergP. Primary non-Hodgkin's lymphoma of the breast: the Mayo Clinic Experience. J Surg Oncol 2002;80:19-25.

https://doi.org/10.1002/jso.10084

How to Cite

[1]
Rodríguez, M. et al. 2004. Primary non-Hodgkin’s lymphomas of the breast: 23 years of experience at the Colombian National Cancer Institute. Revista Colombiana de Cancerología. 8, 3 (Sep. 2004), 39–46.

Downloads

Download data is not yet available.

Published

2004-09-01

Issue

Section

Reportes de caso
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views